Table 2.

Subgroup Analysis of IMS 3 with UW-mRS

Study	Treatment Arm	N	Proportion with Primary Outcome	Mean Utility	Utility Difference	95% CI
IMS 3 Overall	TPA alone	222	0.39	0.505	0.036	−0.024 - 0.097
IMS 3 Overall	TPA + Endovascular	434	0.41	0.541	0.036	−0.024 - 0.097
IMS 3, NIHSS 8-19	TPA alone	143	0.52	0.614	0.002	−0.069 - 0.072
IMS 3, NIHSS 8-19	TPA + Endovascular	285	0.51	0.612	0.002	−0.069 - 0.072
IMS 3, NIHSS ≥20	TPA alone	71	0.17	0.287	0.101	−0.004 - 0.21
IMS 3, NIHSS ≥20	TPA + Endovascular	130	0.24	0.388	0.101	−0.004 - 0.21